SCHEMBL1760734

SCHEMBL1760734

Cc1cccc2cc3c(ccc4ccccc43)cc12

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 10/20 0.88
ALDH1A1 P00352 7/20 0.88
HSD17B10 Q99714 4/20 0.88
HPGD P15428 3/20 0.88
CYP1B1 Q16678 2/20 0.70
HIF1A Q16665 1/20 0.70
CYP2A6 P11509 6/20 0.67
TSHR P16473 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
HPRT1 P00492 1/20 0.48
FYN P06241 2/20 0.46
ACHE P22303 2/20 0.46
AHR P35869 2/20 0.46
MAPT P10636 2/20 0.46
LCK P06239 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
SLC6A2 P23975 1/20 0.46
ERBB2 P04626 1/20 0.45
MAOA P21397 1/20 0.45
CYP1A1 P04798 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL599400 0.96 CYP1A2 (0.81) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
Phenanthrene SCHEMBL27971170 0.94 CYP1A2 (0.85) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
SCHEMBL598690 0.90 CYP1A2 (0.92) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
SCHEMBL598230 0.86 CYP1A2 (0.65) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
SCHEMBL130783 0.84 CYP1A2 (0.69) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
SCHEMBL10560099 0.84 CYP1A2 (0.62) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
SCHEMBL28666046 0.84 CYP2A6 (0.94) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
SCHEMBL11727728 0.83 CYP1A2 (0.69) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
Dibenz[A,H]Anthracene SCHEMBL156100 0.83 ALDH1A1 (1.00) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1
SCHEMBL3975663 0.83 ALDH1A1 (0.88) CYP1A2ALDH1A1HSD17B10HPGDCYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12540073-B2 Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor BRILLIANT LIGHT POWER, INC. (US) 2026-02-03 US disclosed
US-20230045778-A9 HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR BRILLIANT LIGHT POWER, INC. (US) 2023-02-09 US disclosed
US-20200299130-A1 HETEROGENEOUS HYDROGEN-CATALYST REACTOR BRILLIANT LIGHT POWER, INC. (US) 2020-09-24 US disclosed
US-20110114075-A1 HETEROGENEOUS HYDROGEN-CATALYST REACTOR BRILLIANT LIGHT POWER, INC. 2011-05-19 US disclosed
EP-2318307-A2 HETEROGENEOUS HYDROGEN-CATALYST REACTOR Blacklight Power, Inc. (US) 2011-05-11 EP disclosed
WO-2010014684-A2 HETEROGENEOUS HYDROGEN-CATALYST REACTOR BLACKLIGHT POWER, INC. (US) 2010-02-04 WO disclosed
US-5358860-A Using peroxide substrate as oxidant THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 1994-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12540073-B2 Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor SCO2, SOD1, HAO2 CYP1A2 1592/4885ALDH1A1 3874/4885HSD17B10 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.